Catch A Vibe: Connecting LAI-PrEP patients with community support to address health-related social needs
Official title: A Community-Based Intervention To Address Health-Related Social Needs For Patients On LAI-PrEP
Run by NYU Langone Health · NCT07116629 · Data updated 2026-11-12
This observational study tests a community-based approach to screen for health-related social needs among people on LAI-PrEP and connect them to local resources through two partner organizations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 343 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT07116629 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) on or initiating LAI-PrEP who identify as Black/Latine and as a cisgender woman or MSM, or as transgender/nonbinary, and who can consent.
✕Probably not a fit
Participants not experiencing health-related social needs or not linked to eligible community resources may not experience direct benefits from referrals.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study aims to scale up screening for health-related social needs at regular provider visits every four months for individuals on LAI-PrEP. It uses patient navigation and formal connections with two community-based organizations to link participants to resources. An EMR-based tracking system will monitor referrals and outcomes to assess implementation success. The focus is on Black/Latine cisgender women, Black/Latine men who have sex with men, and transgender or nonbinary individuals, with participation open to eligible patients and staff at NYU Langone Health and NYC Health + Hospitals/Bellevue.
Why it matters
Potential benefit: If successful, the approach could improve access to social and community resources that support HIV prevention and overall well-being for people on LAI-PrEP.
How similar studies have gone: Previous work in similar community-partnered approaches has shown promise in linking patients to resources, though this exact implementation in LAI-PrEP settings is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For Patient participant group: In order to be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Does not have HIV AND vulnerable for HIV infection per WHO, NHS, and CDC recommendations * On or initiating LAI-PrEP as part of standard of care prior to study participation * Identify as either a Black/Latine cisgender woman OR Black/Latine MSM OR Transgender or Nonbinary Individual * Capacity and willingness to provide consent For Medical Staff participant group: In order to be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Works with patients who go to the Bellevue Pride Center * Be employed at NYU Langone Health or NYC H+H/Bellevue as one of the following occupations * Physician * Clinical Pharmacist * Nurse * Medical Phlebotomist * Social Worker/Navigator * Community Health Worker * Medical Leader (i.e., director of services) For CBO Partner participant group: In order to be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Works with patients who go to the Bellevue Pride Center * Be employed at one of the established CBOs * Capacity and willingness to provide consent For Patient Who Declines LAI-PrEP participant group: In order to be eligible for participation in this study, an individual must meet all of the following criteria: * 18 years of age or older * Declines LAI-PrEP as part of standard of care * Capacity and willingness to provide consent Exclusion Criteria: For Patient participant group: An individual who meets any of the following criteria will be excluded from participation in this study: * Less than 18 years old * Known HIV seropositive status or test positive at screening * Does not identify as one of the listed priority populations * Not fluent in either English or Spanish * Not interested in HIV PrEP * Not willing to consent for study participation * Does not reside within New York State * Pregnant or planning to become pregnant at the time of consent. * Without capacity to consent to participate in the study For Medical Staff participant group: An individual who meets any of the following criteria will be excluded from participation in this study: * Do not work with patients who go to the Bellevue Pride Center * Is not employed at NYU Langone Health or NYC/H+H Bellevue as one of the following occupations * Physician * Clinical Pharmacist * Nurse * Medical Phlebotomist * Social Worker * Community Health Worker * Medical Leader (i.e., directors of services) For CBO Partner participant group: An individual who meets any of the following criteria will be excluded from participation in this study: • Does not work with patients who go to the Bellevue Pride Center For Patient Who Declines LAI-PrEP participant group: An individual who meets any of the following criteria will be excluded from participation in this study: * Less than 18 years old * Interested in initiating LAI-PrEP as part of standard of care or on LAI-PrEP
Where it's running
-
NYC Health + Hospitals/Bellevue
New York, New York, United States Recruiting -
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Robert Pitts, MD — NYU Langone Health
- Study coordinator: Robert Pitts, MD
- Email: robert.pitts@nyulangone.org
- Phone: 301-318-4376
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CommunityRx-Dpeer: peer-led support to help dementia caregivers connect with community resources
This program tests a peer navigator model to help dementia caregivers access personalized community resources and ongoing support over 12 months.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.